Proficio Capital Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Proficio Capital Partners’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-76	Closed	-$6K	–	1682
2019 Q2	$6K	Sell	76 -12	-14%	-$1.07K	﹤0.01%	1170
2019 Q1	$10K	Buy	88 +39	+80%	+$4.26K	﹤0.01%	881
2018 Q4	$5K	Hold	49	–	–	﹤0.01%	874
2018 Q3	$6K	Hold	49	–	–	﹤0.01%	935
2018 Q2	$4K	Buy	49 +10	+26%	+$732	﹤0.01%	1051
2018 Q1	$2K	Sell	39 -21	-35%	-$1.27K	﹤0.01%	1148
2017 Q4	$4K	Buy	60 +15	+33%	+$946	﹤0.01%	1038
2017 Q3	$3K	Buy	45 +27	+150%	+$2.91K	﹤0.01%	1055
2017 Q2	$2K	Sell	18 -8	-31%	-$927	﹤0.01%	1116
2017 Q1	$3K	Buy	26 +23	+767%	+$2.69K	﹤0.01%	1099
2016 Q4	$0	Hold	3	–	–	﹤0.01%	1195
2016 Q3	$0	Hold	3	–	–	﹤0.01%	1156
2016 Q2	$1K	Hold	3	–	–	﹤0.01%	967
2016 Q1	$0	Buy	+3	New	+$354	﹤0.01%	1187

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Proficio Capital Partners's ICPT Position: Q3 2019 in Review

Proficio Capital Partners sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2019, closing a stake of 76 shares — an estimated $6K sold.

Proficio Capital Partners first reported a position in ICPT in Q1 2016 and held it in 14 quarters. The position peaked at $10K in Q1 2019. 188 funds tracked by Wall St. Rank hold ICPT as of Q3 2019.

Proficio Capital Partners reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Proficio Capital Partners sold 76 Intercept Pharmaceuticals, Inc. shares in Q3 2019, an estimated $6K.
Proficio Capital Partners first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2016 and held it in 14 quarters.
Proficio Capital Partners's Intercept Pharmaceuticals, Inc. position peaked at $10K in Q1 2019.
188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.